Airbnb, the world’s largest accommodation provider, owns no property. Uber, the largest taxi firm, owns no cars.
Facebook, the most popular media company, creates no content & Alibaba, the most valuable retailer, carries no stock.
These disruptors rock the boat; replacing old business models with new effectiveness.
Similarly, the Grace Gawler Institute, via our Cancer Navigation Service is disrupting traditional, fragmented, outdated models of cancer medicine & care.
These slow-to-change medical models, despite good intention & massive government investment, are unable to assist all cancer patients – especially those with rare, difficult or advanced cancers.
When patients are told – there is nothing more we can do – that frightening statement may speak more to the limitations of our medical systems, than to the broader truth.
That truth being – standards of cancer care vary globally; e.g. medicines approved in the USA may take years to be approved in Australia, NZ or the UK.
Most often today, your treatment plan doesn’t have all that much to do with you specifically. It’s identical to what doctors would hand over to essentially anyone with the same condition — your neighbour, the hot dog vendor at Wrigley Field, or the prime minister of Bangladesh. GENOME MAG read more
Good News: Our Cancer Navigation Service is here to guide – especially when your hospital can’t help anymore…
We’ve got your back – SIMPLES!
Cancer medicine changed dramatically with the mapping of the human genome.
Then came Pharmacogenomics – which quickly showed us that unless cancer medicines were genetically targeted or personalised, they would experience a high failure rate.
Outdated Models: The old models stratify patients into groups for the efficient distribution of medicines & treatments. (genomic tests can indicate the treatments will not work for everybody in the group)
But few hospitals use such tests; so these patients will fail treatment and then be shunted into other treatments which may also not work.
This is trial and error medicine with the patient’s life on the line. It is one size fits all medicine.
And; as our doctor in the picture suggests – one size does not fit all.
Innovation moves slowly in cancer medicine. Unlike small organisations like the Grace Gawler Institute, big medical systems & hospital conglomerates are not medically agile.
Genomic Era: Consequently – the Grace Gawler Institute (GGI) Services moved into the genomic era some years ago.
Today, 2017, we are able to help patients access state-of-the-art genomic diagnostic testing – this in turn identifies targeted treatments better than any previous techniques.
Global Alliance: For many decades we (GGI) have been adding innovative cancer doctors & clinics to our global alliance. Therefore; we are ideally positioned to help patients access targeted treatments based on their tumour’s genetic signature; increasing the probability of positive outcomes.
Hospitals and Precision Medicine (personalised or targeted medicine): While most bigger hospitals are still investigating & researching precision medicine; we can help our patients access precision medicine in current time – NOW